301234 五洲医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.0162.4805.2868.18214.384
总资产报酬率 ROA (%)1.7822.1694.6457.12011.555
投入资产回报率 ROIC (%)1.9822.4335.1878.03413.770

边际利润分析
销售毛利率 (%)18.07914.57617.79821.31122.423
营业利润率 (%)8.6035.1329.83012.83111.346
息税前利润/营业总收入 (%)10.3894.7397.84311.79011.987
净利润/营业总收入 (%)7.5664.1238.37211.29212.964

收益指标分析
经营活动净收益/利润总额(%)59.23472.42495.97199.16997.152
价值变动净收益/利润总额(%)17.43323.0715.8823.221-8.378
营业外收支净额/利润总额(%)-0.625-2.743-1.0253.47215.484

偿债能力分析
流动比率 (X)7.2706.2705.8725.7024.879
速动比率 (X)6.6765.8135.3925.1724.405
资产负债率 (%)10.82312.43012.62511.61014.345
带息债务/全部投入资本 (%)-0.425-0.381-0.1410.4820.214
股东权益/带息债务 (%)-23,173.469-25,807.502-69,374.88020,389.50345,831.505
股东权益/负债合计 (%)823.945704.517692.104761.352597.124
利息保障倍数 (X)5.647-18.460-4.157-7.845-8.341

营运能力分析
应收账款周转天数 (天)74.42477.59675.75662.63060.274
存货周转天数 (天)47.23339.79042.18142.31143.726